½ÃÀ庸°í¼­
»óǰÄÚµå
1608840

¼¼°èÀÇ Ç÷¼ÒÆÇ ÀÀÁý ±â±â ½ÃÀå : Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ½ÃÀå ÇöȲ

Platelet Aggregation Devices Market, By Product, By Application, By End User (Hospitals, Diagnostic Laboratories, and Others ), By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Ç÷¼ÒÆÇ ÀÀÁý ±â±â ½ÃÀåÀº 2024³â 6¾ï 1,170¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. 2024³âºÎÅÍ 2031³â±îÁö 6.6%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î 2031³â¿¡´Â 9¾ï 5,970¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ »ó¼¼³»¿ë
±âÁØ ¿¬µµ 2023³â 2024³â ½ÃÀå ±Ô¸ð 6¾ï1,170¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2019-2023³â ¿¹Ãø ±â°£ 2024-2031³â
¿¹Ãø ±â°£(2024-2031³â) CAGR: 6.60% 2031³â °¡Ä¡ ¿¹Ãø 9¾ï 5,970¸¸ ´Þ·¯
±×¸². Ç÷¼ÒÆÇ ÀÀÁý ±â±â ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2024³â
Platelet Aggregation Devices Market-IMG1

Ç÷¼ÒÆÇ ÀÀÁý ±â±â´Â Ç÷¼ÒÆÇ Àå¾ÖÀÇ Áø´ÜÀ» µ½±â À§ÇØ ÀÓ»ó ÇöÀå¿¡¼­ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. Ç÷¼ÒÆÇÀº Ç÷¾× ÀÀ°í °úÁ¤¿¡ ÇʼöÀûÀ̸ç, Ç÷¼ÒÆÇ ±â´É¿¡ ÀÌ»óÀÌ ÀÖÀ¸¸é ÃâÇ÷°ú Ç÷Àü Çü¼ºÀÇ À§ÇèÀÌ Áõ°¡ÇÕ´Ï´Ù. Ç÷¼ÒÆÇ ÀÀÁý ¿ä¼Ò´Â ´Ù¾çÇÑ ÀÛ¿ëÁ¦¿¡ ¹ÝÀÀÇÏ¿© ÀÀÁýÇÏ´Â ´É·ÂÀ» ÃøÁ¤ÇÏ¿© Ç÷¼ÒÆÇÀÇ ±â´ÉÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ±â¼úÀÇ ¹ßÀüÀ¸·Î ¹Î°¨µµ¿Í ÀçÇö¼ºÀÌ Çâ»óµÈ ÀÚµ¿È­µÈ °í󸮷® °Ë»ç°¡ °¡´ÉÇØÁ³½À´Ï´Ù. Ç÷¼ÒÆÇ Àå¾Ö¸¦ ¼±º°Çϰí Ç×Ç÷¼ÒÆÇ Ä¡·á¸¦ ÃÖÀûÈ­ÇÏ´Â µ¥ µµ¿òÀÌ µÇ±â ¶§¹®¿¡ Ç÷¼ÒÆÇ ÀÀÁý ¿ä¼Ò¿¡ ´ëÇÑ ¼ö¿ä´Â ¸Å¿ì Å®´Ï´Ù.

½ÃÀå ¿ªÇÐ

Ç÷¼ÒÆÇ ÀÀÁý ±â±â ½ÃÀåÀÇ ¼ºÀåÀº ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ÀÌ¿¡ µû¸¥ Ç×Ç÷¼ÒÆÇÁ¦ »ç¿ë Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. ¶ÇÇÑ, »õ·Î¿î ±â±âÀÇ °í±Þ ±â´ÉÀº ¿öÅ©Ç÷ο츦 °³¼±ÇÏ°í ¼öµ¿ °Ë»ç¿¡¼­ ÀÚµ¿ °Ë»ç¹ýÀ¸·ÎÀÇ ÀüȯÀ» ¿ëÀÌÇÏ°Ô ÇÕ´Ï´Ù. ±×·¯³ª ÀÚµ¿ Ç÷¼ÒÆÇ ºÐ¼®±â ½ÃÀåÀº ³ôÀº ºñ¿ë°ú ±âÁ¸ ¼³Ä¡ ±â¹ÝÀ» ´ëüÇÏ´Â µ¥ ¾î·Á¿òÀ» °Þ°í ÀÖ½À´Ï´Ù. ÀӽŠÁß Ç×Ç÷¼ÒÆÇ ¿ä¹ý ¸ð´ÏÅ͸µ, ÇöÀå Áø·á¿ë Ç¥ÁØÈ­µÈ °Ë»ç ÇÁ·ÎÅäÄÝ °³¹ß µî ÀÀ¿ë ºÐ¾ß È®´ë´Â ¼ºÀå ±âȸ°¡ µÉ ¼ö ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

ÀÌ º¸°í¼­´Â ¼¼°è Ç÷¼ÒÆÇ ÀÀÁý ±â±â ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®Çϰí 2023³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2024-2031³â) ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ¿¹ÃøÇÑ º¸°í¼­ÀÔ´Ï´Ù.

¶ÇÇÑ, ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.

¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ ÁÖ¿ä °íÂûµµ Á¦°øÇÕ´Ï´Ù.

¼¼°è Ç÷¼ÒÆÇ ÀÀÁý ±â±â ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, ½ÇÀû, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±âÁØÀ¸·Î Á¤¸®Çß½À´Ï´Ù.

ÁÖ¿ä ±â¾÷À¸·Î´Â Sysmex Corporation, WerfenLife SA, Siemens Healthineers, Sentinel Ch. SpA, Haemonetics Corporation, Chrono-Log Corporation, Bio/Data Corporation, Agredyne Inc., F. Hoffmann-La Roche Ltd., Helena Laboratories Corporation µîÀÌ ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­ÀÇ ÅëÂû·ÂÀ» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ­, ½ÃÀå È®´ë ¹× ¸¶ÄÉÆÃ Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¼¼°è Ç÷¼ÒÆÇ ÀÀÁý ±â±â ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è Ç÷¼ÒÆÇ ÀÀÁý ±â±â ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç °áÁ¤À» ½±°Ô ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
  • ¿µÇ⠺м®
  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Á¦Ç° ¹ß¸Å/½ÂÀÎ
  • PEST ºÐ¼®
  • PORTER ºÐ¼®
  • ÀμöÇÕº´(M&A) ½Ã³ª¸®¿À
  • ¿ªÇÐ

Á¦4Àå Ç÷¼ÒÆÇ ÀÀÁý ±â±â ½ÃÀå, Á¦Ç°º°, 2019³â-2031³â

  • ½Ã½ºÅÛ
  • ½Ã¾à
  • ¼Ò¸ðǰ ¹× ¾×¼¼¼­¸®

Á¦5Àå Ç÷¼ÒÆÇ ÀÀÁý ±â±â ½ÃÀå, ¿ëµµº°, 2019³â-2031³â

  • ÀÓ»ó
  • ¿¬±¸

Á¦6Àå Ç÷¼ÒÆÇ ÀÀÁý ±â±â ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019³â-2031³â

  • º´¿ø
  • Áø´Ü½ÇÇè½Ç
  • ±âŸ(¿¬±¸±â°ü µî)

Á¦7Àå Ç÷¼ÒÆÇ ÀÀÁý ±â±â ½ÃÀå, Áö¿ªº°, 2019³â-2031³â

  • ºÏ¹Ì
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿
  • ¾ÆÇÁ¸®Ä«

Á¦8Àå °æÀï ±¸µµ

  • Sysmex Corporation
  • WerfenLife SA
  • Siemens Healthineers
  • Sentinel Ch. SpA
  • Haemonetics Corporation
  • Chrono-Log Corporation
  • Bio/Data Corporation
  • Aggredyne Inc.
  • F.Hoffmann-La Roche Ltd.
  • Helena Laboratories Corporation

Á¦9Àå ¾Ö³Î¸®½ºÆ® Ãßõ »çÇ×

  • Wheel of Fortune
  • ¾Ö³Î¸®½ºÆ®ÀÇ °ßÇØ
  • COM(Coherent Opportunity Map)

Á¦10Àå Âü°í ¹®Çå°ú Á¶»ç ¹æ¹ý

  • Âü°í ¹®Çå
  • Á¶»ç ¹æ¹ý
  • ÃâÆÇ»ç¿¡ ´ëÇØ
LSH 24.12.20

Platelet aggregation devices market is estimated to be valued at USD 611.7 Mn in 2024 and is expected to reach USD 959.7 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.6% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: 611.7 Mn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 6.60% 2031 Value Projection: 959.7 Mn
Figure. Platelet Aggregation Devices Market Share (%), By Region, 2024
Platelet Aggregation Devices Market - IMG1

Platelet aggregation devices are used in clinical settings to aid in diagnosis of platelet disorders. Platelets are essential for the blood clotting process, and any irregularities in their function can elevate the risk of bleeding or the formation of blood clots. Platelet aggregation devices help evaluate platelet function by measuring their ability to aggregate in response to different agonists. Technological advancements are allowing for automated, high-throughput testing with improved sensitivity and reproducibility. Due to its ability to aid in screening for platelet disorders and optimize antiplatelet therapy, there will be huge demand for platelet aggregation devices.

Market Dynamics

Platelet aggregation devices market growth is driven by growing incidence of cardiovascular diseases and associated increased use of antiplatelet drugs. Advanced features of newer devices are also improving workflow and easing the shift from manual to automated testing methods. However, market faces challenges like high costs of automated platelet analyzers as well as challenges to replace existing installed bases. Expanding applications such as monitoring antiplatelet therapy during pregnancy and developing standardized testing protocols for point-of-care use can offer growth opportunities.

Key features of the study

This report provides in-depth analysis of the global platelet aggregation devices market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global platelet aggregation devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Sysmex Corporation, WerfenLife SA, Siemens Healthineers, Sentinel Ch. SpA, Haemonetics Corporation, Chrono-Log Corporation, Bio/Data Corporation, Aggredyne Inc., F. Hoffmann-La Roche Ltd., and Helena Laboratories Corporation

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global platelet aggregation devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global platelet aggregation devices market

Market Segmentation

  • Product Insights (Revenue, USD Mn, 2019-2031)
    • Systems
    • Reagents
    • Consumables and Accessories
  • Application Insights (Revenue, USD Mn, 2019-2031)
    • Clinical
    • Research
  • End User Insights (Revenue, USD Mn, 2019-2031)
    • Hospitals
    • Diagnostic Laboratories
    • Others (Research Institutes, etc.)
  • Regional Insights (Revenue, USD Mn, 2019-2031)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Sysmex Corporation
    • WerfenLife SA
    • Siemens Healthineers
    • Sentinel Ch. SpA
    • Haemonetics Corporation
    • Chrono-Log Corporation
    • Bio/Data Corporation
    • Aggredyne Inc.
    • F.Hoffmann-La Roche Ltd.
    • Helena Laboratories Corporation

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Platelet Aggregation Devices Market, By Product
    • Platelet Aggregation Devices Market, By Application
    • Platelet Aggregation Devices Market, By End User
    • Platelet Aggregation Devices Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Epidemiology

4. Platelet Aggregation Devices Market, By Product, 2019-2031, (USD Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Reagents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Consumables and Accessories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

5. Platelet Aggregation Devices Market, By Application, 2019-2031, (USD Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trend
  • Clinical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Research
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Platelet Aggregation Devices Market, By End User, 2019-2031, (USD Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Others (Research Institutes, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Platelet Aggregation Devices Market, By Region, 2019 - 2031, (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2024,2027 & 2031, (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2020 - 2031, (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, By Application, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, By End User, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, By Application, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, By End User, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, By Application, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, By End User, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, By Application, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, By End User, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, By Application, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, By End User, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, By Application, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, By End User, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, By Country/Region, 2019 - 2031, (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

8. Competitive Landscape

  • Sysmex Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • WerfenLife SA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Siemens Healthineers
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sentinel Ch. SpA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Haemonetics Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Chrono-Log Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bio/Data Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Aggredyne Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • F.Hoffmann-La Roche Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Helena Laboratories Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦